A citation-based method for searching scientific literature

Carlos F Ibáñez. Cold Spring Harb Perspect Biol 2013
Times Cited: 101



M Takahashi, J Ritz, G M Cooper. Cell 1985
Times Cited: 600




List of shared articles



Times cited

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
4

RET receptor signaling: Function in development, metabolic disease, and cancer.
Masahide Takahashi. Proc Jpn Acad Ser B Phys Biol Sci 2022
3

Disparate phenotypes in two unfavorable pregnancies due to maternal mosaicism of a novel RET gene mutation.
Fang Zhang, Zhiwei Wang, Qian Meng, Jiedong Song, Shuting Yang, Xinxin Tang, Yali Zhao, Shuai Men, Leilei Wang. Clin Chim Acta 2022
0

Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions.
Mariantonia Nacchio, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Elena Vigliar, Tommaso Porcelli, Cristina Luongo, Antonino Iaccarino, Fabio Pagni, Domenico Salvatore,[...]. Expert Rev Endocrinol Metab 2022
0


Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.
Junnan Feng, Yan Li, Bing Wei, Lei Guo, Weihua Li, Qingxin Xia, Chengzhi Zhao, Jiawen Zheng, Jiuzhou Zhao, Rui Sun,[...]. Transl Lung Cancer Res 2022
1

RET kinase inhibitors for RET-altered thyroid cancers.
Danica M Vodopivec, Mimi I Hu. Ther Adv Med Oncol 2022
0

RET signaling pathway and RET inhibitors in human cancer.
Angelina T Regua, Mariana Najjar, Hui-Wen Lo. Front Oncol 2022
0

Selective Targeting of RET Fusions in Lung Cancer.
Jessica J Lin, Justin F Gainor. J Clin Oncol 2022
0


The importance of the RET gene in thyroid cancer and therapeutic implications.
Domenico Salvatore, Massimo Santoro, Martin Schlumberger. Nat Rev Endocrinol 2021
26

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.
Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo. Cancers (Basel) 2021
10

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
21

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
3

Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.
Albana Gattelli, Nancy E Hynes, Ignacio E Schor, Sabrina A Vallone. J Mammary Gland Biol Neoplasia 2020
8

RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.
Massimo Santoro, Marialuisa Moccia, Giorgia Federico, Francesca Carlomagno. Genes (Basel) 2020
39


Intracellular RET signaling pathways activated by GDNF.
Kumi Kawai, Masahide Takahashi. Cell Tissue Res 2020
16

Roles of the RET Proto-oncogene in Cancer and Development.
Masahide Takahashi, Kumi Kawai, Naoya Asai. JMA J 2020
11


RET fusions in solid tumors.
Andrew Y Li, Michael G McCusker, Alessandro Russo, Katherine A Scilla, Allison Gittens, Katherine Arensmeyer, Ranee Mehra, Vincenzo Adamo, Christian Rolfo. Cancer Treat Rev 2019
86

A Review of Driver Genetic Alterations in Thyroid Cancers.
Fatemeh Khatami, Seyed Mohammad Tavangar. Iran J Pathol 2018
9

The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
William Grey, Rosaline Hulse, Anna Yakovleva, Dilyana Genkova, Benjamin Whitelaw, Ellen Solomon, Salvador J Diaz-Cano, Louise Izatt. Endocr Pathol 2017
1

A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma.
Masoumeh Mohammadi, Mehdi Hedayati. Cell J 2017
19

Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia.
Daniel Perea, Jordi Guiu, Bruno Hudry, Chrysoula Konstantinidou, Alexandra Milona, Dafni Hadjieconomou, Thomas Carroll, Nina Hoyer, Dipa Natarajan, Jukka Kallijärvi,[...]. EMBO J 2017
18

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
Valentina De Falco, Francesca Carlomagno, Hong-Yu Li, Massimo Santoro. Best Pract Res Clin Endocrinol Metab 2017
21

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
175

Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.
Marjan Zarif Yeganeh, Sara Sheikholeslami, Golnoush Dehbashi Behbahani, Samaneh Farashi, Mehdi Hedayati. Tumour Biol 2015
18

To bud or not to bud: the RET perspective in CAKUT.
T Keefe Davis, Masato Hoshi, Sanjay Jain. Pediatr Nephrol 2014
43

Novel targets in non-small cell lung cancer: ROS1 and RET fusions.
Justin F Gainor, Alice T Shaw. Oncologist 2013
234